Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $153.64B as of Monday, July 27, 2026.
ENTERPRISE VALUE (EV)
$153.64B
AstraZeneca PLC
Market Cap
$131.45B
Enterprise Value (EV)
$153.64B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AstraZeneca PLC (AZN) | $131.45B | $153.64B |
| Stryker Corporation (SYK)vs › | $129.13B | $141.35B |
| Bristol-Myers Squibb Company (BMY)vs › | $127.75B | $162.64B |
| CVS Health Corp. (CVS)vs › | $136.61B | $203.64B |
| Intuitive Surgical, Inc. (ISRG)vs › | $126.06B | $122.97B |
| Danaher Corporation (DHR)vs › | $138.14B | $156.38B |
| Pfizer Inc. (PFE)vs › | $140.61B | $203.64B |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.57B | $118.42B |
| Medtronic plc (MDT)vs › | $107.81B | $134.25B |
| GSK plc (GSK)vs › | $104.87B | $130.81B |
Market Cap
$131.45B
Total Debt
$27.90B
Cash
$5.71B
Enterprise Value
$153.64B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
